MA
AVNS

Montag & Associates’s Avanos Medical AVNS Stock Holding History

Montag & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,274
Closed -$588K – 320
2018
Q2 		$588K Buy
10,274
+37
+0.4% +$1.96K 0.06% 200
2018
Q1 		$472K Buy
10,237
+237
+2% +$11.3K 0.05% 211
2017
Q4 		$462K Hold
10,000
– – 0.04% 217
2017
Q3 		$450K Hold
10,000
– – 0.05% 198
2017
Q2 		$393K Hold
10,000
– – 0.04% 197
2017
Q1 		$381K Hold
10,000
– – 0.04% 195
2016
Q4 		$370K Hold
10,000
– – 0.04% 194
2016
Q3 		$347K Hold
10,000
– – 0.04% 201
2016
Q2 		$325K Hold
10,000
– – 0.04% 202
2016
Q1 		$287K Hold
10,000
– – 0.04% 207
2015
Q4 		$334K Hold
10,000
– – 0.05% 187
2015
Q3 		$284K Buy
+10,000
New +$349K 0.04% 203

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Montag & Associates's AVNS Position: Q3 2018 in Review

Montag & Associates sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 10,274 shares — an estimated $588K sold.

Montag & Associates first reported a position in AVNS in Q3 2015 and held it in 12 quarters. The position peaked at $588K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

  • Montag & Associates reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
  • Montag & Associates sold 10,274 Avanos Medical shares in Q3 2018, an estimated $588K.
  • Montag & Associates first reported a position in Avanos Medical in Q3 2015 and held it in 12 quarters.
  • Montag & Associates's Avanos Medical position peaked at $588K in Q2 2018.
  • 387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Montag & Associates's 13F filing for Q3 2018, filed 7 Nov 2018.